Aerie Pharmaceuticals competitive analysis

Loading summary...

Explore Aerie Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 22, 2023Compound For Use In The Treatment Of Ocular Disorders3
Jun 9, 2021Combination Therapy3

Latest publications and patents of Aerie Pharmaceuticals New

Explore the latest publications and patents granted to Aerie Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Oct 22, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Aerie Pharmaceuticals

Feb 22, 2023Compound For Use In The Treatment Of Ocular DisordersGranted And Under Opposition
Jun 9, 2021Combination TherapyGranted And Under Opposition

Latest PTAB cases involving Aerie Pharmaceuticals

Discover the latest PTAB cases involving Aerie Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Aerie Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AERIE PHARMACEUTICALS - 6 - -
ALFRED E TIEFENBACHER443 - -
DF MP DORRIES FRANK MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBB12 - - -
GENERICS UK214 - - -